Three times weekly (For example, Monday, Wednesday and Friday) This is equivalent to what was previously expressed as units (1.5 million units/50 mcg). * Note that the above activity is expressed in International Units (1 million International Units/50 mcg).
Table 1: Recommended Dosage for ACTIMMUNE for the Treatment of Patients with CGD and SMO Body Surface Area (m 2)
#ACTIMMUNE INTERFERON GAMMA COPAY ASSISTANCE PROGRAM FULL#
FULL PRESCRIBING INFORMATION: CONTENTS * 1 INDICATIONS AND USAGE 2 DOSAGE AND ADMINISTRATION 2.1ĝosing Information 2.2 Important Administration Instructions 2.3ĝose Modification 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS 5.1Ĝardiovascular Disorders 5.2 Neurologic Disorders 5.3ěone Marrow Toxicity 5.4 Hepatic Toxicity 5.5 Hypersensitivity Reactions 5.6 Renal Toxicity 5.7Ěllergic Reactions to Natural Rubber 6 ADVERSE REACTIONS 6.1Ĝlinical Trials Experience 6.2 Postmarketing Experience 6.3 Immunogenicity 7 DRUG INTERACTIONS 7.1 Myelosuppressive Agents 7.2ĝrugs with Neurotoxic, Hematoxic or Cardiotoxic Effects 7.3 Immunological Preparations 7.4Ğffects on Cytochrome P-450 Pathways 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3ğemales and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.3 Pharmacokinetics 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility 14 CLINICAL STUDIES 14.1Ğffects in Chronic Granulomatous Disease (CGD) 14.2Ğffects in Severe, Malignant Osteopetrosis (SMO) 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied 16.2 Storage and Handling 17 PATIENT COUNSELING INFORMATION * Sections or subsections omitted from the full prescribing information are not listed.
0 kommentar(er)
